MANCUSO, CLARA

MANCUSO, CLARA  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 15 di 15 (tempo di esecuzione: 0.004 secondi).
Titolo Data di pubblicazione Autori
miRNA-regulated gene expression differs in celiac disease patients according to the age of presentation 1-gen-2015 Buoli Comani, GBiondi, AMancuso, CMeneveri, RBarisani, D +
Autoantibodies in patients with interleukin 12 receptor beta 1 deficiency 1-gen-2019 Carbone M.Mancuso C.Bernuzzi F.Invernizzi P. +
Food additives can act as triggering factors in celiac disease: Current knowledge based on a critical review of the literature 1-gen-2019 Mancuso, CBarisani, D
Dietary metallic nanoparticles: a new environmental factor in the development od Celiac Disease? 29-gen-2019 MANCUSO, CLARA
New Therapeutic Targets in Autoimmune Cholangiopathies 1-gen-2020 Gerussi A.Luca M.Cristoferi L.Mancuso C.Carbone M.Invernizzi P. +
Immune system and cholangiocytes: A puzzling affair in primary biliary cholangitis 1-gen-2020 Mancuso, CMilani, CCarbone, MInvernizzi, P +
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 1-gen-2020 Gerussi, ACristoferi, LMalinverno, FMancuso, CMilani, CInvernizzi, PCarbone, M +
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 1-gen-2021 Cristoferi, LauraLucà, MartinaGerussi, AlessioMalinverno, FedericaMancuso, ClaraCiaccio, AntonioBarisani, DonatellaInvernizzi, PietroCarbone, Marco +
Immune-mediated drug-induced liver injury: Immunogenetics and experimental models 1-gen-2021 Gerussi A.Mancuso C.Barisani D.Invernizzi P. +
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 1-gen-2021 Malinverno F.Fagiuoli S.Cristoferi L.Gerussi A.Ronca V.O'Donnell S. E.Mancuso C.Mulinacci G.Palermo A. +
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 1-gen-2021 Gerussi A.Carbone M.Invernizzi P.Casella G.Ciaccio A.Cristoferi L.Crosignani A.Fagiuoli S.Malinverno F.Mancuso C.Massironi S.Milani C.Strazzabosco M. +
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 1-gen-2021 Gerussi A.Ciaccio A.Cristoferi L.Malinverno F.Mancuso C.Massironi S.Milani C.O'Donnell S. E.Ronca V.Barisani D.Fagiuoli S.Crosignani A.Strazzabosco M.Carbone M.Duga S.Invernizzi P. +
Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison 1-gen-2021 Montali, LorenzoGragnano, AndreaMiglioretti, MassimoFrigerio, AlessandraVecchio, LucaGerussi, AlessioCristoferi, LauraMancuso, ClaraLucà, MartinaCarbone, MarcoInvernizzi, Pietro +
Gliadin, through the Activation of Innate Immunity, Triggers lncRNA NEAT1 Expression in Celiac Disease Duodenal Mucosa 1-gen-2021 Gnodi, ElisaMancuso, ClaraBallarini, ElisaMeneveri, RaffaellaBarisani, Donatella +
Dietary nanoparticles interact with gluten peptides and alter the intestinal homeostasis increasing the risk of celiac disease 1-gen-2021 Mancuso, CRe, FRivolta, IGnodi, EBarisani, D +